|
DHX15 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.92139637533728E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.7081000209559E-09 |
| Normal-vs-Stage2 |
2.55230000023587E-07 |
| Normal-vs-Stage3 |
5.15079978669064E-10 |
| Normal-vs-Stage4 |
1.44020018133517E-10 |
| Stage1-vs-Stage2 |
3.441000E-01 |
| Stage1-vs-Stage3 |
1.251810E-01 |
| Stage1-vs-Stage4 |
3.182200E-02 |
| Stage2-vs-Stage3 |
8.687600E-01 |
| Stage2-vs-Stage4 |
5.126800E-01 |
| Stage3-vs-Stage4 |
5.327800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.29290023132E-10 |
| Normal-vs-AfricanAmerican |
3.162200E-03 |
| Normal-vs-Asian |
1.37619999995842E-06 |
| Caucasian-vs-AfricanAmerican |
2.172400E-01 |
| Caucasian-vs-Asian |
9.341800E-01 |
| AfricanAmerican-vs-Asian |
3.095000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.65990554634732E-11 |
| Normal-vs-Female |
4.52989978860785E-10 |
| Male-vs-Female |
2.031400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.15900000392011E-08 |
| Normal-vs-Age(41-60Yrs) |
4.03650002311906E-10 |
| Normal-vs-Age(61-80Yrs) |
1.19190213254683E-11 |
| Normal-vs-Age(81-100Yrs) |
1.086310E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.268840E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.404000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.332600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.486600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.899800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.450400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.337900E-02 |
| Classical-VS-Follicular |
4.224700E-03 |
| Classical-VS-Other |
3.327600E-01 |
| Classical-VS-Normal |
8.86319995174745E-09 |
| Tall-VS-Follicular |
9.835800E-01 |
| Tall-VS-Other |
9.072400E-01 |
| Tall-VS-Normal |
6.08860000195222E-08 |
| Follicular-VS-Other |
9.143200E-01 |
| Follicular-VS-Normal |
7.93080046079808E-10 |
| Other-VS-Normal |
3.501900E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.69310010456059E-10 |
| Normal-vs-N1 |
2.2257999998665E-08 |
| N0-vs-N1 |
6.424400E-01 |
|
|
